Immunocardiology

Professor Hilgendorf works as an interventional cardiologist and deputy of the medical director at Germany’s largest University Heart Center at Freiburg-Bad Krozingen. He leads the high-risk outpatient clinic and engages in clinical trials in the field of lipid therapy, heart failure, immunomodulation, and coronary and structural heart disease. Following his postdoctoral training at the MGH Center for Systems Biology, Boston, MA, USA, he established his own research group in Freiburg, Germany, studying the role of the innate and adaptive immune system in cardiovascular disease and the impact of traditional and non-traditional risk factors.

Cardiovascular disease progression likely results from an imbalance of pro- and anti-inflammatory forces. The Immunocardiology Research Group's mission is to reverse atherosclerosis and optimize healing of cardiac lesions through immunomodulation. We are an interdisciplinary and international group of doctors, researchers and students devoted to translational science. Our laboratory is located at the University Hospital Campus with access to state-of-the art core facilities and expert collaborators. Come and see for yourself...